Why the study?
The 2023 ESC guidelines reclassified left ventricular hypertrabeculation from a separate cardiomyopathy to a phenotypic trait, calling for a reassessment of existing aeromedical certification procedures for aircrew.
Does radiofrequency catheter ablation and beta-blocker therapy eliminate complex ventricular arrhythmias and allow safe return to flying duties in a flight technician with left ventricular hypertrabeculation?
Case Report (n=1)
No
Does radiofrequency catheter ablation and beta-blocker therapy eliminate complex ventricular arrhythmias and allow safe return to flying duties in a flight technician with left ventricular hypertrabeculation?
Answers are grounded in this paper and cite their sources.
In alignment with the 2023 ESC guidelines reclassifying left ventricular noncompaction as a phenotypic trait of hypertrabeculation rather than a distinct cardiomyopathy, individualized risk stratification and successful catheter ablation of ventricular ectopy enabled a flight technician to safely return to flying duties.
For decades, left ventricular hypertrabeculation was regarded as a rare congenital cardiomyopathy characterized by an excessively developed trabecular endocardial layer with deep intertrabecular recesses. It most commonly presented with heart failure, arrhythmias, and/or thromboembolic complications in young adults. Temporary or permanent suspension from flying duties was the usual response to a diagnosis of left ventricular noncompaction (LVNC) cardiomyopathy, given the potential risk of arrhythmia and sudden in-flight incapacitation. However, the 2023 European Society of Cardiology (ESC) guidelines have radically changed the approach to this imaging phenotype. Hypertrabeculation is no longer classified as a separate cardiomyopathy but as a phenotypic trait that may occur in isolation or accompany other heart conditions. This fundamental change in classification calls for a reassessment of existing aeromedical certification procedures and may affect the ability of aircrew previously disqualified on these grounds to continue their careers. The practical implications of this reclassification are illustrated by the case of a 41-year-old flight technician with left ventricular hypertrabeculation. In the era of “the cardiomyopathy that no longer exists,” this case underscores the importance of individual risk assessment and the need to adapt certification procedures to current medical knowledge.
No takes yet. Share an insight, caveat, or question.
Owsiak et al. (2026) conducted a case report in Left ventricular hypertrabeculation (formerly left ventricular noncompaction) with ventricular arrhythmia and nonsustained ventricular tachycardia (n=1). Percutaneous radiofrequency catheter ablation and bisoprolol was evaluated on Ventricular ectopy burden on 24-hour Holter ECG monitoring and fitness to return to flying duties at 6 months.
Synapse has enriched 10 related papers. Consider them for comparative context: